
Citibrisk Plus 500mg/800mg Tablet
Marketer
Starus Pharmaceuticals
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Citibrisk Plus 500mg/800mg Tablet
NeuroMend 500mg/800mg tablets aid in stroke recovery and cognitive function enhancement. This medication safeguards brain cells from injury and facilitates their repair, also finding application in brain injury treatment. NeuroMend can be administered with or without food, ideally at the same time daily for consistent blood levels. Follow your physician's prescribed dosage and duration; if a dose is missed, take it immediately upon recollection. Complete the entire course, even with symptom improvement, and avoid abrupt cessation without consulting your doctor, as this could exacerbate symptoms. Common, typically transient, side effects include heightened energy, abdominal discomfort, anxiety, and hypotension. Persistent or bothersome effects warrant medical attention. Maintain adequate hydration due to potential diarrhea, and manage potential weight gain through balanced nutrition and regular physical activity.
Uses of Citibrisk Plus 500mg/800mg Tablet
Stroke Recovery Program
Major Benefits of Citibrisk Plus 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Citibrisk Plus 500mg/800mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Citibrisk Plus 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Citibrisk Plus 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Citibrisk Plus 500mg/800mg Tablets. Ingest the tablet whole; do not chew, crush, or divide it. This medication can be administered with or without food, although consistent timing is recommended.
How Citibrisk Plus 500mg/800mg Tablet works:
CogniPlus 500mg/800mg tablets combine citicoline and piracetam to support brain health. Citicoline, a neuroprotective agent, fosters neuronal nourishment, shielding cells from injury and enhancing viability. Piracetam, a GABAergic compound, offers cerebral and neurological protection against hypoxia while modulating ion channel activity within neuronal membranes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Citibrisk Plus 500mg/800mg tablets lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citibrisk Plus 500mg/800mg tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Citibrisk Plus 500mg/800mg tablets while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving may be impaired by Citibrisk Plus 500mg/800mg Tablets, which can induce drowsiness and tremor. These side effects could compromise your ability to operate a vehicle.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Citibrisk Plus 500mg/800mg tablets, as dose modification may be necessary. Medical advice should be sought before taking this medication. Citibrisk Plus 500mg/800mg tablets are contraindicated in individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Citibrisk Plus 500mg/800mg tablets in patients with liver conditions is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Citibrisk Plus 500mg/800mg Tablet :
Should you forget a Citibrisk Plus 500mg/800mg Tablet dose, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Citibrisk Plus 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
